Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) had Weighted-Average Shares Outstanding (Diluted) of 40.53M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-11.09M |
|
-- |
|
-- |
|
$11.56M |
|
$-11.56M |
|
$0.41M |
|
$-11.16M |
|
$-11.16M |
|
$-11.10M |
|
$-11.10M |
|
$-11.10M |
|
$-11.10M |
|
$-11.56M |
|
$-10.66M |
|
40.53M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
40.53M |
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$77.79M |
|
$3.52M |
|
$20.38M |
|
$98.17M |
|
$10.02M |
|
-- |
|
$13.86M |
|
$23.88M |
|
$74.29M |
|
$60.00M |
|
$74.29M |
|
40.85M |
|
| Cash Flow Statement Financials | |
$-47.98M |
|
$0.42M |
|
$0.00M |
|
$112.40M |
|
$71.85M |
|
$-40.55M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.95% |
|
-18.50% |
|
-11.31% |
|
-14.95% |
|
$1.82 |
|
$-1.17 |
|
$-1.18 |
|